Search research articles
Contact Us
Filters
Showing results (1-10 of 461) with videos related to
Page
of 47
Sort By:
Gastroenterology & Hepatology
|
October 28, 2010
Understanding combination therapy with biologics and immunosuppressives for the treatment of Crohn's disease
Jean-Frederic Colombel
Nature Reviews. Gastroenterology & Hepatology
|
October 15, 2014
Decade in review-IBD: IBD-genes, bacteria and new therapeutic strategies
Jean-Frederic Colombel
Gastroenterology
|
December 14, 2016
Inflammatory Bowel Disease 2017: Innovations and Changing Paradigms
Jean-Frederic Colombel, Uma Mahadevan
Gastrointestinal Endoscopy Clinics of North America
|
May 13, 2019
Treat-to-Target in Inflammatory Bowel Diseases, What Is the Target and How Do We Treat?
Manasi Agrawal, Jean-Frederic Colombel
Nature Reviews. Gastroenterology & Hepatology
|
December 15, 2020
The intestinal barrier, an arbitrator turned provocateur in IBD
Saurabh Mehandru, Jean-Frederic Colombel
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 16, 2017
Need for Caution in Diagnosis of Irritable Bowel Syndrome in Patients With Inflammatory Bowel Disease
Robert Hirten, Jean-Frederic Colombel
Gastroenterology
|
January 29, 2014
Reply: To PMID 23644079
Jacques Cosnes, Jean-Frederic Colombel
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 23, 2015
Reply
Natasha Kamal, Jean-Frederic Colombel
Alimentary Pharmacology & Therapeutics
|
November 7, 2023
Letter: 'No first among equals'-Authors' reply
Maia Kayal, Jean Frederic Colombel
The Lancet. Gastroenterology & Hepatology
|
February 5, 2022
Treat to target with ustekinumab for Crohn's disease
Ryan C Ungaro, Jean-Frederic Colombel
Page
of 47
Search research articles
Search
Showing results (1-10 of 461) with videos related to
Sort By:
Page
of 47
Gastroenterology & Hepatology
|
October 28, 2010
Understanding combination therapy with biologics and immunosuppressives for the treatment of Crohn's disease
Jean-Frederic Colombel
Nature Reviews. Gastroenterology & Hepatology
|
October 15, 2014
Decade in review-IBD: IBD-genes, bacteria and new therapeutic strategies
Jean-Frederic Colombel
Gastroenterology
|
December 14, 2016
Inflammatory Bowel Disease 2017: Innovations and Changing Paradigms
Jean-Frederic Colombel, Uma Mahadevan
Gastrointestinal Endoscopy Clinics of North America
|
May 13, 2019
Treat-to-Target in Inflammatory Bowel Diseases, What Is the Target and How Do We Treat?
Manasi Agrawal, Jean-Frederic Colombel
Nature Reviews. Gastroenterology & Hepatology
|
December 15, 2020
The intestinal barrier, an arbitrator turned provocateur in IBD
Saurabh Mehandru, Jean-Frederic Colombel
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 16, 2017
Need for Caution in Diagnosis of Irritable Bowel Syndrome in Patients With Inflammatory Bowel Disease
Robert Hirten, Jean-Frederic Colombel
Gastroenterology
|
January 29, 2014
Reply: To PMID 23644079
Jacques Cosnes, Jean-Frederic Colombel
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 23, 2015
Reply
Natasha Kamal, Jean-Frederic Colombel
Alimentary Pharmacology & Therapeutics
|
November 7, 2023
Letter: 'No first among equals'-Authors' reply
Maia Kayal, Jean Frederic Colombel
The Lancet. Gastroenterology & Hepatology
|
February 5, 2022
Treat to target with ustekinumab for Crohn's disease
Ryan C Ungaro, Jean-Frederic Colombel
Page
of 47